A mixed‐methods study of cyclin‐dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers
2015 ◽
Vol 152
(1)
◽
pp. 77-85
◽
2020 ◽
2007 ◽
Vol 16
(5)
◽
pp. 433-438
◽